Calithera Biosciences (NASDAQ:CALA) Now Covered by Analysts at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report issued on Sunday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Calithera Biosciences stock opened at $0.00 on Friday. Calithera Biosciences has a 1 year low of $0.00 and a 1 year high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.